February 1, 2008 - Volume 47 - Issue 2 - Contributor Index

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):212-220, February 1, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1, 2008.

Risk of Hepatitis-Related Mortality Increased Among Hepatitis C Virus/HIV-Coinfected Drug Users Compared With Drug Users Infected Only With Hepatitis C Virus: A 20-Year...

Smit, Colette; van den Berg, Charlotte; Geskus, Ronald; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):221-225, February 1, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1, 2008.

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 Infection

Lewin, Sharon R; Murray, John M; Solomon, Ajantha; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):140-147, February 1, 2008.